View in EDS HTML Full Text PDF Full Text

Management of Facial Immune Checkpoint Inhibitor-Induced Vitiligo with Topical Ruxolitinib: Quantitative Assessment Using a Semi-Automatic Tool.

Saved in:
Bibliographic Details
Title: Management of Facial Immune Checkpoint Inhibitor-Induced Vitiligo with Topical Ruxolitinib: Quantitative Assessment Using a Semi-Automatic Tool.
Authors: Breakell, Thomas1,2,3 (AUTHOR) thomas.breakell@uk-erlangen.de, Neri, Paolo2,4 (AUTHOR), Staats, Léonie A. N.1,2,3 (AUTHOR), Kramer, Rafaela1,2,3,4 (AUTHOR), Berking, Carola1,2,3 (AUTHOR), Erdmann, Michael1,2,3 (AUTHOR), Hartmann, Anke1,2,3 (AUTHOR)
Source: Current Oncology. May2026, Vol. 33 Issue 5, p300. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11980052
DOI:10.3390/curroncol33050300